Suppr超能文献

发病机制、感染预防与治疗。

Pathogenesis, Infection Prevention and Treatment.

作者信息

Miggiano Riccardo, Rizzi Menico, Ferraris Davide M

机构信息

Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.

出版信息

Pathogens. 2020 May 18;9(5):385. doi: 10.3390/pathogens9050385.

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment" that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.

摘要

结核病(TB)是由结核分枝杆菌(MTB)引起的一种传染病,由于多种复杂的生物学和社会学原因,它对公共卫生构成持续威胁。根据世界卫生组织(WHO)编辑的最新《全球结核病报告》(2019年),结核病被认为是全球第九大致死原因,也是单一感染源导致死亡的主要原因,感染率和死亡率最高的情况大多集中在发展中国家和低收入国家。在此,我们展示了题为“结核分枝杆菌的发病机制、感染预防与治疗”的特刊社论部分,该特刊包含7篇研究文章和1篇综述。该特刊中的科学贡献主要集中在结核病流行国家出现的MTB菌株的特征描述,以及细菌为抵抗和适应抗结核治疗所采用的多种机制。

相似文献

1
Pathogenesis, Infection Prevention and Treatment.
Pathogens. 2020 May 18;9(5):385. doi: 10.3390/pathogens9050385.
5
[Recent progress in mycobacteriology].
Kekkaku. 2007 Oct;82(10):783-99.
6
The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
Tuberculosis (Edinb). 2018 Dec;113:200-214. doi: 10.1016/j.tube.2018.10.009. Epub 2018 Oct 30.
8
Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
Acc Chem Res. 2019 Aug 20;52(8):2340-2348. doi: 10.1021/acs.accounts.9b00275. Epub 2019 Jul 30.
9
Recent updates on drug resistance in Mycobacterium tuberculosis.
J Appl Microbiol. 2020 Jun;128(6):1547-1567. doi: 10.1111/jam.14478. Epub 2019 Oct 29.

引用本文的文献

1
Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies.
Front Cell Infect Microbiol. 2025 May 8;15:1567592. doi: 10.3389/fcimb.2025.1567592. eCollection 2025.
3
Clinical characteristics and prognostic factors of pulmonary tuberculosis with interstitial changes.
BMC Infect Dis. 2025 Apr 29;25(1):624. doi: 10.1186/s12879-025-10970-y.
4
Development and validation of a nomogram for predicting pulmonary embolism in patients with pulmonary tuberculosis.
J Thorac Dis. 2025 Mar 31;17(3):1197-1206. doi: 10.21037/jtd-24-1627. Epub 2025 Mar 27.
5
Detection of Mycobacteria in Arabian camels and antimycobacterial potential of Moringa oleifera.
Sci Rep. 2025 Apr 4;15(1):11590. doi: 10.1038/s41598-025-92402-0.
6
The relationship between ferroptosis and respiratory infectious diseases: a novel landscape for therapeutic approach.
Front Immunol. 2025 Mar 18;16:1550968. doi: 10.3389/fimmu.2025.1550968. eCollection 2025.
7
Mycobacterium tuberculosis: The Mechanism of Pathogenicity, Immune Responses, and Diagnostic Challenges.
J Clin Lab Anal. 2024 Dec;38(23):e25122. doi: 10.1002/jcla.25122. Epub 2024 Nov 26.
9
Treatment and Toxicity Considerations in Tuberculosis: A Narrative Review.
Cureus. 2024 Jun 19;16(6):e62698. doi: 10.7759/cureus.62698. eCollection 2024 Jun.
10
Asthmatic patients with vitamin D deficiency: Can vitamin D supplementation make a difference.
Technol Health Care. 2024;32(6):3985-4008. doi: 10.3233/THC-231462.

本文引用的文献

1
Preclinical Evidence of Nanomedicine Formulation to Target at Its Bone Marrow Niche.
Pathogens. 2020 May 13;9(5):372. doi: 10.3390/pathogens9050372.
2
4
Intelligent Mechanisms of Macrophage Apoptosis Subversion by .
Pathogens. 2020 Mar 16;9(3):218. doi: 10.3390/pathogens9030218.
5
Targeting Genome Integrity in : From Nucleotide Synthesis to DNA Replication and Repair.
Molecules. 2020 Mar 7;25(5):1205. doi: 10.3390/molecules25051205.
7
MmpS5-MmpL5 Transporters Provide Resistance to imidazo[1,2-][1,2,4,5]tetrazines.
Pathogens. 2020 Feb 28;9(3):166. doi: 10.3390/pathogens9030166.
8
Metabolic Changes of during the Anti-Tuberculosis Therapy.
Pathogens. 2020 Feb 18;9(2):131. doi: 10.3390/pathogens9020131.
10
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验